Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Aafact
(monoclonal purified factor VIII) /
Sanquin
Welcome,
Profile
Billing
Logout
0 Diseases
2 Trials
2 Trials
4 News
|
|||||||||
New P4 trial:
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients. Implementatie van farmacokinetisch gestuurd doseren van profylaxe bij hemofilie patienten.
(EUDRACT) - Dec 21, 2018
P4
, N=50, ,
Sponsor: Erasmus University Medical Center